Forteo and Soliris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Forteo (teriparatide recombinant human) and Soliris (eculizumab). Common drug interactions include blood glucose increased among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Forteo and Soliris. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Forteo?

Forteo has active ingredients of teriparatide recombinant human. It is often used in osteoporosis. eHealthMe is studying from 127,076 Forteo users. Check the latest studies of Forteo.

What is Soliris?

Soliris has active ingredients of eculizumab. It is often used in paroxysmal nocturnal hemoglobinuria (pnh). eHealthMe is studying from 58,821 Soliris users. Check the latest studies of Soliris.

On Jul, 30, 2026

18 people who take Forteo and Soliris together, and have interactions are studied.

What are the common drug interactions of Forteo and Soliris, by gender? *:

female:

Blood glucose increased
Blood potassium decreased
Contusion (a type of hematoma of tissue in which capillaries)
Dizziness
Drug ineffective
Dyspnoea exertional (breathlessness or shortness of breath)
Flushing (the warm, red condition of human skin)
Gait disturbance
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
Hypertension (high blood pressure)

male:

Drug ineffective
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
Pneumonia
Viral infection
Muscle spasms (muscle contraction)

What are the common drug interactions of Forteo and Soliris, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Drug ineffective
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
Dizziness
Dyspnoea exertional (breathlessness or shortness of breath)
Flushing (the warm, red condition of human skin)
Gait disturbance
Headache (pain in head)
Hypertension (high blood pressure)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Oedema peripheral (superficial swelling)

What are the existing conditions these people have? *

Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 13 people, 72.22%
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid): 4 people, 22.22%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 11.11%
Aplastic Anemia: 2 people, 11.11%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 11.11%
Migraine (headache): 2 people, 11.11%
Insomnia (sleeplessness): 2 people, 11.11%
High Blood Pressure: 2 people, 11.11%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 2 people, 11.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Forteo and Soliris?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously